These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11361823)

  • 1. New gel formulation for saquinavir.
    AIDS Patient Care STDS; 1997 Oct; 11(5):373-4. PubMed ID: 11361823
    [No Abstract]   [Full Text] [Related]  

  • 2. Why the old saquinavir (Invirase) may be bad for your health.
    Vazquez E
    Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soft gel saquinavir has high exposure.
    AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saquinavir switch study stopped.
    Treat Rev; 1997 Apr; (No 24):6. PubMed ID: 11364285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saquinavir (Fortovase or Invirase).
    Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182
    [No Abstract]   [Full Text] [Related]  

  • 6. NDA submitted for new formulation of saquinavir.
    AIDS Patient Care STDS; 1997 Aug; 11(4):288-9. PubMed ID: 11361847
    [No Abstract]   [Full Text] [Related]  

  • 7. Fortovase approved: new saquinavir formulation.
    James JS
    AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions. Coming soon--a new formulation of saquinavir (Invirase).
    TreatmentUpdate; 2006; 18(3):9. PubMed ID: 17209243
    [No Abstract]   [Full Text] [Related]  

  • 9. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saquinavir update.
    Treat Rev; 1997 Aug; (No 25):6. PubMed ID: 11364616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg.
    Ananworanich J; Siangphoe U; Mahanontharit A; Hill A; Hirschel B; Ruxrungtham K
    Antivir Ther; 2004 Dec; 9(6):1035-6. PubMed ID: 15651763
    [No Abstract]   [Full Text] [Related]  

  • 12. Saquinavir with grapefruit juice.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting the optimum dose for a new soft gelatin capsule formulation of saquinavir. NV15107 Study Group.
    Lalezari J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):195-7. PubMed ID: 9768631
    [No Abstract]   [Full Text] [Related]  

  • 14. Pill burden reduced for saquinavir.
    AIDS Patient Care STDS; 2005 Feb; 19(2):128. PubMed ID: 15747430
    [No Abstract]   [Full Text] [Related]  

  • 15. Twice daily saquinavir.
    AIDS Patient Care STDS; 1999 May; 13(5):307. PubMed ID: 10356812
    [No Abstract]   [Full Text] [Related]  

  • 16. [The new saquinavir formulation SGC (Soft Gel Capsule)].
    Katlama C
    Presse Med; 1999 Apr; 28(15):815-8. PubMed ID: 10325942
    [No Abstract]   [Full Text] [Related]  

  • 17. Boosted saquinavir approved.
    AIDS Patient Care STDS; 2004 Mar; 18(3):183. PubMed ID: 15112642
    [No Abstract]   [Full Text] [Related]  

  • 18. [New formulation--fewer tablets--optimal effect].
    Krankenpfl J; 2005; 43(7-10):249. PubMed ID: 16515318
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. Starting therapy with saquinavir.
    TreatmentUpdate; 2007 Jan; 19(1):8-9. PubMed ID: 17393566
    [No Abstract]   [Full Text] [Related]  

  • 20. Searching for the right dose of ritonavir-saquinavir.
    TreatmentUpdate; 2001 Sep; 13(5):3. PubMed ID: 11768860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.